“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group-Reference-Cited by-同舟云学术

“Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group

Published:2013-07-28 Issue:1 Volume:93 Page:129-139
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Katodritou Eirini,Vadikolia Chrysanthi,Lalagianni Chrysavgi,Kotsopoulou Maria,Papageorgiou Georgia,Kyrtsonis Marie-Christine,Matsouka Panagiota,Giannakoulas Nikolaos,Kyriakou Despoina,Karras Georgios,Anagnostopoulos Nikolaos,Michali Evridiki,Briasoulis Evangelos,Hatzimichael Eleftheria,Spanoudakis Emmanouil,Zikos Panagiotis,Tsakiridou Anastasia,Tsionos Konstantinos,Anargyrou Konstantinos,Symeonidis Argiris,Maniatis Alice,Terpos Evangelos

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-013-1841-y.pdf

Reference29 articles.

1. Kyle RA, Rajkumar SV (2008) Multiple myeloma. Blood 111:2962–2972

2. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16:481–488

3. Richardson PG, Mitsiades C, Schlossman R, Munshi N, Anderson K (2007) New drugs for myeloma. Oncologist 12:664–689

4. Kastritis E, Zervas K, Symeonidis A, Terpos E, Delimbassi S, Anagnostopoulos N, Michali E, Zomas A, Katodritou E, Gika D, Pouli A, Christoulas D, Roussou M, Kartasis Z, Economopoulos T, Dimopoulos MA (2009) Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG). Leukemia 23:1152–1157

5. Palumbo A, San Miguel J, Sonneveld P, Moreau P, Drach J, Morgan G, Einsele H (2008) Lenalidomide: a new therapy for multiple myeloma. Cancer Treat Rev 34:283–291

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study;Cancers;2023-12-14

2. A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study;Hematology;2023-02-19

3. Exosomal circ-CACNG2 promotes cardiomyocyte apoptosis in multiple myeloma via modulating miR-197-3p/caspase3 axis;Experimental Cell Research;2022-08

4. Combined lenalidomide/bortezomib for multiple myeloma complicated by fulminant myocarditis: a rare case report of widely used chemotherapy;European Heart Journal - Case Reports;2022-02-22

5. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment;Oncology and Therapy;2021-10-16